Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-19-057696
Filing Date
2019-11-21
Accepted
2019-11-21 21:07:39
Documents
1
Period of Report
2019-11-19

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 6140
  Complete submission text file 0001209191-19-057696.txt   7506
Mailing Address 1010 ATLANTIC AVENUE SUITE 102 ALAMEDA CA 94501
Business Address
SEGALL JUDITH (Reporting) CIK: 0001054745 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38519 | Film No.: 191238576

Mailing Address 965 ATLANTIC AVENUE SUITE 101 ALAMEDA CA 94501
Business Address 965 ATLANTIC AVENUE SUITE 101 ALAMEDA CA 94501 510-671-8370
AgeX Therapeutics, Inc. (Issuer) CIK: 0001708599 (see all company filings)

EIN.: 821436829 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations